Core Scientific (CORZ) Change in Accured Expenses (2020 - 2026)

Core Scientific (CORZ) has 7 years of Change in Accured Expenses data on file, last reported at -$16.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 703.28% year-over-year to -$16.4 million; the trailing twelve-month figure through Mar 2026 stood at -$36.5 million (down 344.08% YoY), and the FY2025 full-year result was -$17.4 million, down 1025.53% from the prior year.
• Change in Accured Expenses advanced to -$16.4 million in Q1 2026, from -$42.3 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $117.4 million in Q4 2023 to a low of -$42.3 million in Q4 2025.
• A 5-year average of $6.8 million and a median of $1.4 million in 2024 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses sank 1042.49% in 2024 and jumped 2409.47% in 2025, its largest moves.
• Tracing CORZ's Change in Accured Expenses over 5 years: stood at $17.5 million in 2022, then soared by 571.9% to $117.4 million in 2023, then sank by 60.17% to $46.8 million in 2024, then plunged by 190.56% to -$42.3 million in 2025, then surged by 61.36% to -$16.4 million in 2026.
• Business Quant data shows CORZ's Change in Accured Expenses at -$16.4 million in Q1 2026, -$42.3 million in Q4 2025, and $34.7 million in Q3 2025.